[1] | Chanda M, Allan C, and Innocent C. Low occurrence of tuberculosis drug resistance among pulmonary tuberculosis patients from an urban setting, with a long-running DOTS program in Zambia.2010. Tuberculosis Research and Treatment, vol. 2010, Article ID 938178, 6 pages, 2010. |
|
[2] | Hillemann D, Gerdes RS, and Richter E. Evaluation of Genotype MTBDR plus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2007;45:2635e40. |
|
[3] | Huang H, Jin Q, Ma Y, Chen X, and Zhuang Y. Characterization of rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis isolated in China. Tuberculosis (Edinburgh).2002, 82(2-3): 79-83. |
|
[4] | Kent P T and Kubica G P. Public health mycobacteriology: a guide for the level III laboratory, p. 64-68. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Atlanta, GA.1985. |
|
[5] | Kocagoz T, Saribas Z, and Alp A. Rapid determination of rifampin resistance in clinical isolates of Mycobacterium tuberculosis by real-time PCR. J. Clin. Microbiol.2005, 43(12): 6015-60. |
|
[6] | Koch R. Die Aetiologie der Tuberculosis. Berl. Klinische Wochenschr.1882, 100(12): 539. |
|
[7] | Lavender C, Globan M, Sievers A, Jacobe HB, and Fyfe J. Molecular characterization isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia. Antimicrob. Agents. Chemother.2005, 49(10): 4068-4074. |
|
[8] | Loddenkemper R, and Hauer B. Drug-Resistant Tuberculosis. Dtsch. Arztebl. Int.2010, 107(1-2): 10-19. |
|
[9] | Migliori GB, Matteelli A, Cirillo D, and Pai M. Diagnosis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: Current standards and challenges. Can J Infect Dis Med Microbiol.2008; 19(2):169-172. |
|
[10] | Mokrousov I, Narvskaya O, Otten T, Limeschenko E, Steklova L and Vyshnevskiy B. High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001. Antimicrob Agents Chemother.2002; 46, 1417-1424. |
|
[11] | Pai M, Minion J, and Sohn H. Novel and improved technologies for tuberculosis diagnosis: progress and challenges. Clin Chest Med.2009; 30: 701-716. |
|
[12] | Paramasivan CN and Venkataraman P. Drug resistance in 5. tuberculosis in India. Indian J Med Res.2004; 120 : 377-86. |
|
[13] | Piatek A S, Telenti A, Murray M R, El-Hajj H, Jacobs W R, Kramer F R and Alland D. Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob Agents Chemother.2002; 44, 103-110. |
|
[14] | Sahm D, and Weissfeld F. Bailey and Scott’s diagnostic microbiology. (11th ed.). St. Louis, MO7 Mosby, pp 3-29.2002. |
|
[15] | Schneider E, and Castro KG. Tuberculosis trends in the United States, 1992-2001. Tuberculosis (Edinb) 83:21-29.2003. |
|
[16] | Sethi S, Sharma S, and Sharma SK. Drug susceptibility of Mycobacterium tuberculosis to primary antitubercular drugs by nitrate reductase assay. Indian J Med Res.2004; 120:468-471. |
|
[17] | Sharma SK and Mohan A. Multidrug-resistant tuberculosis: a 2. menace that threatens to destabilize tuberculosis control. Chest.2006; 130: 261-72. |
|
[18] | Singla R, Sarin R, and Khalid UK. Seven-year DOTS-Plus pilot experience in India: results, constraints and issues. Int J Tuberc Lung Dis.2009; 13: 976-81. |
|
[19] | World Health Organization. WHO Report 2011: Global Tuberculosis Control. (2011) Available: http://www.who.int/tb/publications/global_report/ en/. Accessed 2012 Oct 20. |
|
[20] | World Health Organization. Country cooperation strategy at a glance. Available at: www.who.int / country focus / cooperation_strategy /ccsbrief_egy_en.pdf.2009. |
|
[21] | World Health Organization. Global Tuberculosis Control - A short update to the 2009 report. |
|
[22] | World Health organization. Tuberculosis country profiles.2011. Available at : www.who.int/tb/country/data/profile. |
|
[23] | Yang S, Zhong M, Zhang Y and Wang Y. Rapid detection of rpoB and katG genes from the sputum of multidrug-resistant Mycobacterium tuberculosis by polymerase chain reaction (PCR)-direct sequencing analysis. African Journal of Microbiology Research. 2011; 5(26), 4519-4523. |
|
[24] | Yang Z, Durmaz R, Yang D, Gunal S, Zhang L, Foxman B, Sanic A, and Marrs CF. Simultaneous detection of isoniazid, rifampin, and ethambutol resistance of Mycobacterium tuberculosis by a single multiplex allele-specific polymerase chain reaction (PCR) assay. Diagnostic Microbiology and Infectious Diseas;.2005, 53; 201-208. |
|
[25] | Yue J, Shi W, Xie J, Li Y, Zeng E and Wang H. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from China. J Clin Microbiol. 2003;41, 2209-2212. |
|